Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-59,027
Closed -$1.47M 1492
2025
Q4
$1.47M Sell
59,027
-1,496
-2% -$37.7K 0.08% 289
2025
Q3
$1.54M Buy
60,523
+40,118
+197% +$990K 0.1% 270
2025
Q2
$495K Sell
20,405
-12,899
-39% -$301K 0.05% 602
2025
Q1
$844K Buy
33,304
+9,221
+38% +$241K 0.09% 341
2024
Q4
$639K Buy
24,083
+4,987
+26% +$135K 0.08% 381
2024
Q3
$553K Sell
19,096
-1,266
-6% -$36.9K 0.05% 616
2024
Q2
$570K Buy
+20,362
New +$561K 0.08% 410
2024
Q1
Sell
-6,456
Closed -$186K 1765
2023
Q4
$186K Buy
+6,456
New +$195K 0.04% 641

Other funds holding PFE

AlphaQuest's PFE Position: Q1 2026 in Review

AlphaQuest sold out of Pfizer (PFE) in Q1 2026, closing a stake of 59,027 shares — an estimated $1.47M sold.

AlphaQuest first reported a position in PFE in Q4 2023 and held it in 8 quarters. The position peaked at $1.54M in Q3 2025. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • AlphaQuest reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 59,027 Pfizer shares in Q1 2026, an estimated $1.47M.
  • AlphaQuest first reported a position in Pfizer in Q4 2023 and held it in 8 quarters.
  • AlphaQuest's Pfizer position peaked at $1.54M in Q3 2025.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.